NL1025072A1 - Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing. - Google Patents

Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing.

Info

Publication number
NL1025072A1
NL1025072A1 NL1025072A NL1025072A NL1025072A1 NL 1025072 A1 NL1025072 A1 NL 1025072A1 NL 1025072 A NL1025072 A NL 1025072A NL 1025072 A NL1025072 A NL 1025072A NL 1025072 A1 NL1025072 A1 NL 1025072A1
Authority
NL
Netherlands
Prior art keywords
quinazolin
methylpyridin
phenylamino
yloxy
acetamide
Prior art date
Application number
NL1025072A
Other languages
English (en)
Other versions
NL1025072C2 (nl
Inventor
John Charles Kath
Jason Albert Leonard
Andrew Vincent Trask
Zheng Jane Li
Daniel Tyler Richter
Joel Morris
Carl Brian Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL1025072A1 publication Critical patent/NL1025072A1/nl
Application granted granted Critical
Publication of NL1025072C2 publication Critical patent/NL1025072C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL1025072A 2002-12-19 2003-12-18 Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing. NL1025072C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43470002P 2002-12-19 2002-12-19
US43470002 2002-12-19

Publications (2)

Publication Number Publication Date
NL1025072A1 true NL1025072A1 (nl) 2004-06-22
NL1025072C2 NL1025072C2 (nl) 2007-07-24

Family

ID=32682089

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1025072A NL1025072C2 (nl) 2002-12-19 2003-12-18 Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing.

Country Status (21)

Country Link
US (1) US20050075354A1 (nl)
EP (1) EP1575936A1 (nl)
JP (1) JP2006512355A (nl)
KR (1) KR20050085835A (nl)
CN (1) CN1726208A (nl)
AR (1) AR042508A1 (nl)
AU (1) AU2003283743A1 (nl)
BR (1) BR0317259A (nl)
CA (1) CA2509140A1 (nl)
GT (1) GT200300287A (nl)
MX (1) MXPA05006582A (nl)
NL (1) NL1025072C2 (nl)
NO (1) NO20052803L (nl)
PA (1) PA8592501A1 (nl)
PE (1) PE20040915A1 (nl)
PL (1) PL377533A1 (nl)
RU (1) RU2005122659A (nl)
TW (1) TW200424191A (nl)
UY (1) UY28129A1 (nl)
WO (1) WO2004056802A1 (nl)
ZA (1) ZA200504621B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
JP2008542356A (ja) * 2005-06-03 2008-11-27 ファイザー・プロダクツ・インク 異常な細胞増殖の治療用の二環式誘導体
RS59494B1 (sr) 2010-02-12 2019-12-31 Pfizer Soli i polimorfi 8-fluoro-2-{4-[(metilamino)metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4, 3-cd]indol-6-ona
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
GEP20063831B (en) * 2000-06-22 2006-05-25 Pfizer Prod Inc Substituted bicyclic derivatives for treatment of abnormal cell growth
ATE377009T1 (de) * 2001-11-30 2007-11-15 Osi Pharm Inc Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
HUP0402662A2 (hu) * 2001-12-12 2005-05-30 Pfizer Products Inc. Az E-2-metoxi-N-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi)fenilamino]kinazolin-6-il}-allil)acetamid sói, előállításuk és rák elleni alkalmazásuk
AP2004003058A0 (en) * 2001-12-12 2004-06-30 Pfizer Prod Inc Quinazoline derivatives for the treatment of abnormal cell growth.

Also Published As

Publication number Publication date
CN1726208A (zh) 2006-01-25
WO2004056802A1 (en) 2004-07-08
NO20052803L (no) 2005-09-16
EP1575936A1 (en) 2005-09-21
GT200300287A (es) 2004-11-30
UY28129A1 (es) 2004-07-30
PE20040915A1 (es) 2005-01-18
MXPA05006582A (es) 2005-08-16
TW200424191A (en) 2004-11-16
BR0317259A (pt) 2005-11-08
NO20052803D0 (no) 2005-06-09
PL377533A1 (pl) 2006-02-06
RU2005122659A (ru) 2006-01-20
JP2006512355A (ja) 2006-04-13
AU2003283743A1 (en) 2004-07-14
CA2509140A1 (en) 2004-07-08
PA8592501A1 (es) 2004-09-16
NL1025072C2 (nl) 2007-07-24
KR20050085835A (ko) 2005-08-29
US20050075354A1 (en) 2005-04-07
AR042508A1 (es) 2005-06-22
ZA200504621B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
DE602005012190D1 (de) Träger , Entwickler, Bildherstellungsverfahren und Arbeitseinheit
DE60319662D1 (de) Piezoelektrischer Oszillator, dessen Herstellungsverfahren und elektronisches Bauteil
DE602004000683D1 (de) Fingerabdrucksensor und dessen Herstellungsverfahren
NL1026892A1 (nl) ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie.
IS7881A (is) CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni
DE60330400D1 (de) Sprachsynthesesystem, Sprachsyntheseverfahren und Rechnerprogramm
NL1025148A1 (nl) Benzamideremmers van de P2X7-receptor.
BR0313373B1 (pt) processo para fabricação contìnua de artigos descartáveis de vestir.
DE60225161D1 (de) Zinkgewinnungsverfahren
NL1025839A1 (nl) Chinoline- en chinoxalineverbindingen.
ATE390422T1 (de) Quinazolin-derivate für die behandling von krebs
NO20021559L (no) Fremgangsmåte til gjenvinning av ammoniakk
ATE550017T1 (de) Lasofoxifen-tablette und ihre ummantelung
NL1024495A1 (nl) Werkwijze voor het verbeteren van de productie van Fischer-Tropsch-destillaatbrandstoffen.
DE602004012039D1 (de) Diffusionsbeschichtungsverfahren
DE502004005362D1 (de) Auslegung von werkzeugen und prozessen für die umformtechnik
DE60211082D1 (de) Toner und Tonerherstellungsverfahren
NL1025072A1 (nl) Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing.
NO20032125D0 (no) Gassgjenvinningsprosess
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
ITMI20011205A0 (it) Processo integrato di produzione di 2,6 dimetilfaftalene
BR0304252B1 (pt) processo de produÇço de pà de monàxido de niàbio, monàxido de niàbio, e, capacitor.
DE102004007617A8 (de) Verfahren zur Herstellung von Vliesstoffen, Vliesstoffe und deren Verwendung
NL1017421A1 (nl) Werkwijze voor het vervaardigen van paroxetine.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20070523

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20080701